Topic: NHS England

NHS England’s partnerships with data companies like Palantir raise significant concerns about patient privacy and data sharing without consent. The lack of transparency in how health data is handled and the potential for misinformation highlight the risks of surveillance and censorship within public health initiatives. These issues are critical for those who advocate for individual rights and free expression in the face of increasing state control over personal information.